| 通報號: G/TBT/N/CAN/465 |
ICS號: 11.120
|
發布日期: 2015-08-05
|
截至日期: 2015-10-15
|
通報成員: 加拿大
|
目標和理由: 保護人類安全和健康
|
內容概述: 聯合國麻醉藥品委員會投票贊成將3種2C-苯乙胺衍生物（25B-NBOMe、25C-NBOMe和25I-NBOMe）列入聯合國精神藥物公約1971一攬表I中。2C-苯乙胺是具有興奮和致幻性質的高效合成致幻劑。作為“策劃藥”，該藥迅速出現在市場上。此類策劃藥容易在網絡上及舞會、夜總會和時裝店銷售。在全球范圍內，這些產品與重大健康與安全風險相關。2C-苯乙胺沒有合法治療或工業用途，僅限于科學研究使用。 本公告給相關利益方提供機會，評議加拿大衛生部關于受管制藥品及物質法案（CDSA）一攬表III及食品藥品法規（FDR）第J部分一攬表修訂提案，以便包括2C-苯乙胺及其鹽類、衍生物、同分異構體，和衍生物與同分異構體及其鹽類。這將包括25B-NBOMe、25C-NBOMe和25I-NBOMe及其鹽類。
|
正文:
| 世界貿易組織 |
G/TBT/N/CAN/465
2015-08-05
15-4028
|
| |
| 技術性貿易壁壘 |
原文：英語/法語
|
通 報
以下通報根據TBT協定第10.6條分發
| 1. |
通報成員: 加拿大
如可能，列出涉及的地方政府名稱 ( 3.2條和7.2 條)：
|
| 2. |
負責機構:衛生部
|
| 3. |
通報依據條款:2.9.2
|
| 4. |
覆蓋的產品： 2C-苯乙胺及其鹽類、衍生物、同分異構體，衍生物與同分異構體及其鹽類。 ICS: 11.120
HS編碼:30 ICS編碼:11.120
|
| 5. |
通報標題： 給相關利益方的公告－受管制藥品及物質法案（CDSA）一攬表III及食品藥品法規（FDR）第J部分一攬表修訂提案，以便包括2C-苯乙胺及其鹽類、衍生物、同分異構體，和衍生物與同分異構體及其鹽類。
語言：英語和法語 頁數：2 鏈接網址：
|
| 6. |
內容簡述： 聯合國麻醉藥品委員會投票贊成將3種2C-苯乙胺衍生物（25B-NBOMe、 25C-NBOMe和25I-NBOMe）列入聯合國精神藥物公約1971一攬表I中。2C-苯乙胺是具有興奮和致幻性質的高效合成致幻劑。作為“策劃藥”，該藥迅速出現在市場上。此類策劃藥容易在網絡上及舞會、夜總會和時裝店銷售。在全球范圍內，這些產品與重大健康與安全風險相關。2C-苯乙胺沒有合法治療或工業用途，僅限于科學研究使用。
本公告給相關利益方提供機會，評議加拿大衛生部關于受管制藥品及物質法案（CDSA）一攬表III及食品藥品法規（FDR）第J部分一攬表修訂提案，以便包括2C-苯乙胺及其鹽類、衍生物、同分異構體，和衍生物與同分異構體及其鹽類。這將包括25B-NBOMe、 25C-NBOMe和25I-NBOMe及其鹽類。
|
| 7. |
目標與理由:保護人類健康。
|
| 8. |
相關文件: 2015年8月1日加拿大官方公報第I部分第2158-2159頁（英語和法語）
|
| 9. |
擬批準日期:預計2016年春
擬生效日期:法規批準之日
|
| 10. |
意見反饋截止日期： 2015/10/15
|
| 11. |
文本可從以下機構得到:
|
|
正文(英):
NOTIFICATION
The following notification is being circulated in accordance with Article 10.6
|
1.
|
Notifying Member: Canada
If applicable, name of local government involved (Article 3.2 and 7.2):
|
|
2.
|
Agency responsible: Health Canada
Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above:
Canada's Notification Authority and Enquiry Point
Foreign Affairs, Trade and Development Canada
Technical Barriers and Regulations Division (TIB)
111 Sussex Drive
Ottawa, ON K1A 0G2
Canada
Tel: (343) 203-4273
Fax: (613) 943-0346
E-mail: enquirypoint@international.gc.ca
|
|
3.
|
Notified under Article 2.9.2 [X], 2.10.1 [ ], 5.6.2 [ ], 5.7.1 [ ], other:
|
|
4.
|
Products covered (HS or CCCN where applicable, otherwise national tariff heading. ICS numbers may be provided in addition, where applicable): 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers (ICS: 11.120)
|
|
5.
|
Title, number of pages and language(s) of the notified document: Notice to Interested Parties – Proposed Order amending Schedule III to the Controlled Drugs and Substances Act (CDSA) and Regulations Amending the Schedule to Part J of the Food and Drug Regulations (FDR) to include 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers (2 pages, available in English and French)
|
|
6.
|
Description of content: The United Nations Commission on Narcotic Drugs voted in favour of scheduling three 2C-phenethylamines derivatives, 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe, under Schedule I to the United Nations Convention on Psychotropic Substances 1971. 2C-phenethylamines are potent synthetic hallucinogens having both stimulant and hallucinogenic properties. Considered as "designer drugs", they are emerging in the market at a rapid pace. These designer drugs are readily available for sale on the internet as "research chemicals" and at raves, nightclubs and head shops. Around the world, these products have been associated with significant health and safety risks. There are no known legitimate therapeutic or industrial uses and only limited scientific and research uses for 2C-phenethylamines.
This notice provides interested stakeholders with the opportunity to comment on Health Canada's intent to pursue amendments to Schedule III to the CDSA and the Schedule to Part J of the FDR to include 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers. This would include 25B-NBOMe, 25C-NBOMe and 25I?NBOMe and their salts.
|
|
7.
|
Objective and rationale, including the nature of urgent problems where applicable: Protection of human health
|
|
8.
|
Relevant documents: Canada Gazette, Part I, 1 August 2015, Pages 2158-2159 (Available in English and French)
|
|
9.
|
Proposed date of adoption: Anticipated for spring 2016
Proposed date of entry into force: On the date the regulations are adopted
|
|
10.
|
Final date for comments: 15 October 2015
|
|
11.
|
Texts available from: National enquiry point [X] or address, telephone and fax numbers and email and website addresses, if available, of other body:
The electronic version of the notice can be downloaded at:
http://www.gazette.gc.ca/rp-pr/p1/2015/2015-08-01/pdf/g1-14931.pdf
http://www.gazette.gc.ca/rp-pr/p1/2015/2015-08-01/html/notice-avis-eng.php#nb4
http://www.gazette.gc.ca/rp-pr/p1/2015/2015-08-01/html/notice-avis-fra.php#nb4
|
|
| |
|
